Sunday, Nov 29, 2020 | Last Update : 07:56 PM IST

Biocon India

Exclusive | Kiran Majumdar Shaw on how Biocon hopes to beat COVID-19

Kiran Mazumdar Shaw, Biocon’s executive chairperson, is delighted that Biocon’s COVID-19 drug Itolizumab is DCGI-approved

15 Jul 2020 8:17 PM

Future jobs will be different: Shaw

It is important that the country focused on affordability to ensure that technology is accessible to all.

07 Mar 2019 1:21 AM

ADVERTISEMENT
ADVERTISEMENT